All news are regularly updated on our institutional homepage
The news feature on our institution homepage gives up to date updates on new developments at MES.
Invited talk
As the world counts down to the 2030 deadline of the UN agenda, major economies like China and Germany are encountering common challenges, which call…
Local media press release about blood test for detection of pancreatic cancer
Our work on early detection of pancreatic cancer in patients blood raised public interest. We continue to thrive for better future care for patients and…
New publication on transcriptional classification of breast cancer susceptibility to immune therapy
A chromatin regulator-related gene signature was calculated, and this signature provides the strong independent predictive capability for clinical prognosis and immunotherapy efficacy for patients …
New publication on blood-based molecular stratification of pancreatic cancer
In a collaboration between the partner sites Heidelberg and Dresden of the National Center for Tumor Diseases (NCT) a blood extracellular-vesicle-transported mRNA signature to discriminate…
Cancer Neuroscience
As part of the NEURO-ONCOLOGY WORKING GROUP (NOA) in the German Cancer Association (DKG) we had the pleasure to moderate a webinar on fundamentals, current…
New publication on immune therapy against MYC-driven malignancy
The findings suggest a dynamic relationship between MYC amplification and innate immune suppression in MYC amplified neoplasms and support further investigation of phagocytosis modulation as…
New Membership
Accreditation approved to participate in European network on 3R - Replace, Refine, Reduce animal research. Excited to participate in WG1 on "Quality and Translatability of…
New publication on MET alterations informing on therapy sensitivity
MET F/SVs but not genomic amplification, were highly enriched in the secondary glioblastomas (sGBM) and marked worse prognosis. Further molecular and scRNA-seq analysis revealed that…
“All THIS MESS: checking validity in clinical studies.”
Data Prevalence is defining co-founder in statistics. Thanks for your visit Dr. Klimova from NCT partner site Dresden.